Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prokidney (PROK) Enterprise Value (2022 - 2025)

Historic Enterprise Value for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $1.2 billion.

  • Prokidney's Enterprise Value fell 639.17% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 639.17%. This contributed to the annual value of $1.3 billion for FY2024, which is 952.61% down from last year.
  • As of Q3 2025, Prokidney's Enterprise Value stood at $1.2 billion, which was down 639.17% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, Prokidney's Enterprise Value peaked at $1.8 billion during Q1 2023, and registered a low of $1.1 billion during Q3 2022.
  • For the 4-year period, Prokidney's Enterprise Value averaged around $1.3 billion, with its median value being $1.3 billion (2024).
  • Its Enterprise Value has fluctuated over the past 5 years, first surged by 2904.52% in 2023, then tumbled by 2408.51% in 2024.
  • Quarter analysis of 4 years shows Prokidney's Enterprise Value stood at $1.1 billion in 2022, then rose by 29.05% to $1.4 billion in 2023, then fell by 9.53% to $1.3 billion in 2024, then decreased by 5.12% to $1.2 billion in 2025.
  • Its Enterprise Value was $1.2 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.3 billion in Q1 2025.